Dr Robert H Dixon, MD | |
20 York St, Bath, ME 04530-2721 | |
(207) 443-4511 | |
(207) 493-5784 |
Full Name | Dr Robert H Dixon |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 20 York St, Bath, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447356720 | NPI | - | NPPES |
002121 | Other | ME | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 6933 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert H Dixon, MD 20 York St, Bath, ME 04530-2721 Ph: (207) 443-4511 | Dr Robert H Dixon, MD 20 York St, Bath, ME 04530-2721 Ph: (207) 443-4511 |
News Archive
A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues.
A study led by researchers at the University of Minnesota Medical School sheds new light on boys' weapon-carrying behaviors at U.S. high schools. The results indicate that weapon-carrying is not tied to students' race or ethnicity but rather their schools' social climates.
In what is believed to be the first interview-style qualitative study of its kind among health care providers in the trenches, a team led by a Johns Hopkins geriatrician has further documented barriers to better care of older adults as they are transferred from hospital to rehabilitation center to home, and too often back again.
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Central Ohio Primary Care Physicians (COPCP), the second largest privately-owned primary care group in the United States, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 230 physicians across 44 practices.
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.
› Verified 6 days ago